Self-sacrificial tyrosine cleavage by an Fe:Mn oxygenase for the biosynthesis of <i>para</i>-aminobenzoate in <i>Chlamydia trachomatis</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36122239.
- Also identified by DOI 10.1073/pnas.2210908119 and PMC identifier 9522330.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chlamydia protein associating with death domains (CADD) is involved in the biosynthesis of <i>para</i>-aminobenzoate (pABA), an essential component of the folate cofactor that is required for the survival and proliferation of the human pathogen <i>Chlamydia trachomatis</i>. The pathway used by <i>Chlamydiae</i> for pABA synthesis differs from the canonical multi-enzyme pathway used by most bacteria that relies on chorismate as a metabolic precursor. Rather, recent work showed pABA formation by CADD derives from l-tyrosine. As a member of the emerging superfamily of heme oxygenase-like diiron oxidases (HDOs), CADD was proposed to use a diiron cofactor for catalysis. However, we report maximal pABA formation by CADD occurs upon the addition of both iron and manganese, which implicates a heterobimetallic Fe:Mn cluster is the catalytically active form. Isotopic labeling experiments and proteomics studies show that CADD generates pABA from a protein-derived tyrosine (Tyr27), a residue that is ∼14 Å from the dimetal site. We propose that this self-sacrificial reaction occurs through O<sub>2</sub> activation by a probable Fe:Mn cluster through a radical relay mechanism that connects to the "substrate" Tyr, followed by amination and direct oxygen insertion. These results provide the molecular basis for pABA formation in <i>C. trachomatis</i>, which will inform the design of novel therapeutics.
Medical subject headings
- Bacterial Proteins
- Chlamydia trachomatis
- Oxygenases
- Tyrosine
- para-Aminobenzoates